NetworkNewsBreaks Archive - Page 2114 of 2180

MondayMar 20, 2017 10:14 am

NetworkNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Establishes XiBiDi Biotechnology Co., Ltd. in Shanghai Free-Trade Zone

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced the establishment and registration of XiBiDi Biotechnology Co., Ltd. in the Shanghai Free-Trade Zone. Moving forward, XiBiDi will focus on the online and offline sales of health products featuring hemp-derived cannabidiol (CBD) oil, in addition to hemp-based food and beverages. Additionally, the new company will serve as operator of CIIX’s recently-launched CBD online store, www.ChineseCBDoil.com. “I am delighted about the establishment and registration of our new hemp company,” Warren Wang, founder and CEO of CIIX, stated in this morning’s news release. “XiBiDi Biotechnology is strategically located in the Pudong Free-Trade…

FridayMar 17, 2017 12:34 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on March 17, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: XGTI 16.90% – News: Posts final payment on deferred debt from Vislink acquisition ABUS 14.04% – News: Moving on momentum from recent license agreement NSPXD 12.50% – News: Signs agreement with Milost Global, Inc. for a commitment of up to $100M AVID 5.62% – News: Law firm announces investigation SITO 5.50% – News: Law firm issues reminder for class action lead plaintiff deadline of April 18 GLBR 5.05% – News: Law firm issues reminder…

FridayMar 17, 2017 12:31 pm

NetworkNewsBreaks – Acura Pharmaceuticals (ACUR) Inks License Agreement with MainPointe Pharmaceuticals for Nexafed® Products

Acura Pharmaceuticals (OTCQB: ACUR) shares are up 5% on news that the company has entered into a License Agreement with MainPointe Pharmaceuticals, LLC in which MainPointe will exclusively market NEXAFED and NEXAFED Sinus in the U.S. and Canada. The NEXAFED brand products, which contain pseudoephedrine, utilize Acura’s IMPEDE® Technology, which disrupts the extraction and conversion of pseudoephedrine into the illicit drug methamphetamine. MainPointe will assume all manufacturing and commercialization activities from Acura. Per the agreement, MainPointe is required to make an upfront cash payment of $2.5 million to Acura, as well as royalty payments of 7.5% based on commercial sales by…

FridayMar 17, 2017 12:28 pm

NetworkNewsBreaks – BioSig Technologies, Inc. (BSGM) Signs Strategic Agreement with Mayo Clinic

BioSig Technologies (OTCQB: BSGM) shares rose 10% after the company signed a 10-year strategic agreement with Mayo Clinic and Mayo Clinic Ventures. The new agreement expands upon the work realized under the Advanced Clinical Research Program that was signed with Mayo Clinic in March 2016. The company intends to work closely with leading Mayo electrophysiologists Drs. Samuel Asirvatham and K. L. Venkatachalam to develop advanced clinical features and applications for its PURE EP System, in addition to leveraging its experience in physiologic signal processing to develop future technologies. Mayo is expected to contribute knowledge, intellectual property and clinical support to the partnership. The…

FridayMar 17, 2017 11:31 am

NetworkNewsBreaks – Singlepoint, Inc. (SING) CEO Discusses Convectium Acquisition in Interview on MoneyTV

Full-service mobile technology and marketing provider Singlepoint, Inc. (OTC: SING) is a featured company on this week’s episode of MoneyTV with Donald Baillargeon. MoneyTV is an internationally syndicated television program about “money and what makes it happen.” To view the show, visit www.MoneyTV.net. In this week’s episode, Singlepoint CEO Greg Lambrecht discusses the company’s recently completed acquisition of a stake in Convectium, the creator of the 710Shark and 710Seal system for filling and packaging vape cartridges and disposable vape pens. “The [Convectium] business is doing extremely well, they’ve been in a couple of tradeshows and are selling a lot of…

FridayMar 17, 2017 10:52 am

NetworkNewsBreaks – Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) Enters Agreement to Merge with Molecular Templates; Shares Soar

Threshold Pharmaceuticals (NASDAQ: THLD) shares soared 41% following early morning news that the company has entered into a definitive agreement to merge with Molecular Templates, Inc., a privately held biopharmaceutical company. Per the agreement, Molecular Templates will merge with a wholly-owned subsidiary of Threshold in an all-stock transaction, resulting in a combined Nasdaq-listed company focused on the development of novel treatments for cancer. At the close of the transaction, Longitude Capital will invest $20 million, subject to certain conditions, including the receipt of additional equity financing commitments of $20 million. Molecular Templates’ proprietary technology has been used to create biologic…

ThursdayMar 16, 2017 12:35 pm

NetworkNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) CEO Featured in Benzinga Article

India Globalization Capital (NYSE: IGC) was recently featured in an article detailing the company's strategic move to the cannabis industry and future plans for the company. In the past, IGC was a company primarily focused on the beneficiation of iron ore. That focus changed a few years ago when iron ore prices plummeted, often selling below its cost of production. For the last three years, the company has shifted its focus to tackling the cannabis industry, or more specifically, medical cannabis use. The company is currently developing a portfolio to address epilepsy, cachexia, PTSD, Alzheimer’s, and Parkinson’s. “We came up…

ThursdayMar 16, 2017 12:32 pm

NetworkNewsBreaks – Heat Biologics (NASDAQ: HTBX) Receives Grant to Develop Zika Vaccine

Heat Biologics, Inc. (NASDAQ: HTBX) this morning said Natasa Strbo, M.D., D.Sc., research assistant professor of Microbiology and Immunology at the University of Miami Miller School of Medicine, has received a three-year $981,901 grant from the Florida Department of Health 2016-17 Zika Research Grant Initiative to further develop and test the gp96-based Zika vaccine. The vaccine is being developed under a collaboration between the University of Miami and Heat’s wholly owned subsidiary, Zolovax, Inc., which has licensed the patent. The grant is expected to cover the preclinical development of the Zika vaccine, and allow Dr. Strbo to expand her laboratory…

ThursdayMar 16, 2017 12:24 pm

NetworkNewsBreaks – Avid’s (NASDAQ: AVID) Avid NEXIS™ Selected by Middlesex University; Shares Sink

Avid® (NASDAQ: AVID) shares are down 18% in mid-day trade. The company this morning said that the Faculty of Arts and Creative Industries at Middlesex University in London has invested in Avid NEXIS™. Powered by the MediaCentral® Platform, Avid NEXIS provides the reliability, performance and scalability that the faculty needs to support the expanding department and prepare graduates for success in the media industries. The university faculty and stake holders have invested in Avid NEXIS | E4 and Avid NEXIS | E2 systems with the addition of a System Director Appliance for the flexibility to support the increasing needs of…

ThursdayMar 16, 2017 10:40 am

NetworkNewsBreaks – Player’s Network, Inc. (PNTV) Announces Engagement of NetworkNewsWire

Diversified holding company Player's Network, Inc. (OTCQB: PNTV) this morning announced its engagement of NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company that delivers a new generation of social communication solutions, news aggregation and syndication, and enhanced news release services. Leveraging an investor-based distribution network that includes more than 5,000 key syndication outlets, various newsletters, numerous social media channels, blogs, and other outreach tools, NNW will look to generate greater brand awareness for Player’s Network as the company seeks to expand its presence in both the media and cannabis industries. “This partnership is an extension of our new shareholder…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks